Laboratorio Libra

What Laboratorio Libra does

Laboratorio Libra S.A. is a privately-held Uruguayan pharmaceutical company with more than 60 years of history producing, importing, and exporting pharmaceutical products across Latin America. It operates a GMP-certified manufacturing plant in Montevideo (Arroyo Grande) that produces injectable antibiotics under WHO Good Manufacturing Practices, making it the only GMP-certified injectable antibiotics manufacturer in Uruguay. The company also holds dual GMP certifications from Uruguay's Ministry of Health and Brazil's ANVISA, and its 2,400 sqm logistics center (Camino Carrasco) operates under WHO Good Storage and Distribution Practices. Its product portfolio spans antiretrovirals (Lamicavir, STIGRA, INBEC), specialty injectables, antithrombotics (Thromban/Apixaban, FDA-approved), ophthalmic solutions (Dorzotim Plus), immunosuppressants (Lenalidomida, Mycophenolic Acid), parenteral nutrition (SmofKabiven), and representations of international brands including Seroquel (Luye Pharma).

The company generates revenue through direct sales of manufactured products and through representation/distribution agreements with international pharmaceutical manufacturers such as Luye Pharma (Seroquel) and Emcure Pharmaceuticals (STIGRA, INBEC). Its go-to-market is sales-led, using an in-house sales force and distribution network to serve healthcare professionals, pharmacies, hospitals, and government health institutions across Uruguay, with export operations into Ecuador (via Libra Ecuador subsidiary established in 2019), Brazil, and other Latin American markets. Additional services include pharmacovigilance monitoring across the product lifecycle. The company also runs scientific events, medical congresses, and healthcare professional newsletters as part of its medical-affairs-led marketing approach.

Customer segments are primarily healthcare professionals and patients in Uruguay, with government health institutions (Uruguay Ministry of Health, Brazil Ministry of Health) as important institutional buyers. The company has demonstrated capacity for cross-border supply, notably delivering ICU medications to Brazilian states during COVID-19 under a bilateral health agreement. No external investors, public listings, funding rounds, or M&A activity are disclosed; the company appears to be founder-owned or privately held.

Name

Laboratorio Libra

Legal name

Laboratorio Libra S.A.

Website

https://lablibra.com

Company type

Private

Founded year

1961

Operating status

Operating

Headcount range

101–250 employees

Short description

Laboratorio Libra is a 60+ year-old Uruguayan pharmaceutical manufacturer that produces, imports, and distributes GMP-certified specialty medicines — including the only GMP-certified injectable antibiotics in Uruguay — to healthcare professionals, patients, and government health institutions across Latin America.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro industry

PRIMARYHLAIABAC

Sterile Injectable Generics

Healthcare & Life Sciences/Pharmaceuticals/Generic Pharmaceuticals

SECONDARYHLAIABAM

Generic Tender & Government Supply Markets

Healthcare & Life Sciences/Pharmaceuticals/Generic Pharmaceuticals

SECONDARYCRAOAHAA

Prescription Pharmaceutical (Rx) Wholesale Distribution

Consumer Products & Retail/Wholesale, Distribution & Category Management/Health, OTC & Pharmacy Wholesale Distribution

Keywords

• Pharmaceutical manufacturing
• Injectable antibiotics
• Antiretroviral medications
• GMP-certified production
• Specialty pharmaceuticals

Headquarters

HQ city

Montevideo

HQ country

Uruguay

HQ region

Latin America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Laboratory Libra produces, imports, exports, and commercializes pharmaceutical products including specialty medications, generics, and antiretroviral drugs. Revenue is generated through direct sales of manufactured products and products under representation agreements with international pharmaceutical companies.
2. Product Representation/Agency: Commercialization of products on behalf of international pharmaceutical companies (e.g., Seroquel for Luye Pharma Corporation) in Uruguay and Latin American markets.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Laboratorio Libra manufactures, imports, exports, and commercializes pharmaceutical products from Uruguay, including specialty medications, antiretrovirals, injectable antibiotics, ophthalmic solutions, immunosuppressants, and parenteral nutrition. The company operates the only GMP-certified injectable antibiotics plant in Uruguay and also represents international pharmaceutical companies (such as Luye Pharma and Emcure Pharmaceuticals) in distributing their products across Uruguay and Latin America.

Product overview

Laboratorio Libra is a Uruguayan pharmaceutical company with over 60 years of experience producing, exporting, and importing pharmaceutical products recognized throughout Latin America. The company operates an FDA-approved injectable antibiotic manufacturing facility and maintains GMP certifications from Uruguay's Ministry of Health and ANVISA (Brazil). The product portfolio includes antiretroviral medications (Seroquel, INBEC, STIGRA, Lamicavir), cardiovascular/thrombotic drugs (Thromban), ophthalmic solutions (Dorzotim Plus®), immunosuppressants (Lenalidomida Libra, Ácido micofenólico EMS), and parenteral nutrition (SmofKabiven®), complemented by pharmacovigilance services that monitor medication safety throughout the product lifecycle.

Differentiator

Problem solved

Functional benefit

Products and services

• Seroquel Seroquel (Quetiapine) is an antipsychotic medication available in multiple presentations (25 mg, 100 mg, 200 mg, XR 50 mg, XR 200 mg, XR 300 mg). It is commercialized by Laboratorio Libra in Uruguay on behalf of Luye Pharma Corporation, for use by healthcare professionals treating patients requiring antipsychotic therapy.
• INBEC INBEC is an antiretroviral fixed-dose combination tablet containing 600 mg Abacavir (as sulfate), 50 mg Dolutegravir (as sodium salt), and 300 mg Lamivudine, for treatment of HIV patients by healthcare professionals in Uruguay and Latin America.
• STIGRA STIGRA is an antiretroviral medication containing Dolutegravir. It is an interchangeable medication sourced from Emcure Pharmaceuticals Ltd. (India) and distributed by Laboratorio Libra for HIV treatment.
• Thromban Thromban is an oral antithrombotic medication containing Apixaban 2.5/5 mg. It is bioequivalent and FDA approved, used by healthcare professionals for anticoagulation therapy.
• Dorzotim Plus® Dorzotim Plus is an ophthalmic solution containing Dorzolamide (20 mg/mL), Timolol (5 mg/mL), and Brimonidine Tartrate (3 mg/mL), used as an ocular antihypertensive for the treatment of glaucoma and related conditions.
• Lamicavir Lamicavir is an antiretroviral fixed-dose combination tablet containing Abacavir 600 mg + Lamivudine 300 mg. It is WHO prequalified for use in international HIV treatment programs, supplied to healthcare institutions in Uruguay and Latin America.
• Lenalidomida Libra Lenalidomida Libra is an immunomodulatory drug used in the treatment of multiple myeloma and other related conditions, available for healthcare professionals in Uruguay and the region.
• Ácido micofenólico EMS Ácido micofenólico EMS is an immunosuppressant medication used to prevent organ rejection after transplantation, supplied to healthcare institutions.
• SmofKabiven® SmofKabiven is a complementary parenteral nutrition product for patients requiring nutritional support via intravenous administration, used in hospital and clinical settings.
• Farmacovigilancia (Pharmacovigilance) Pharmacovigilance service that monitors medication safety from development through the entire product lifecycle, performing activities for detection, assessment, understanding, and prevention of adverse events for all products distributed by Laboratorio Libra.

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered core.

• Luye Pharma CorporationcoreChannel Partner/ Reseller/ Distributor · 1 October 2024Laboratorio Libra commercializes Seroquel in Uruguay on behalf of Luye Pharma Corporation. Following successful registration transfer with the Ministry of Public Health, all Seroquel presentations (25mg, 100mg, 200mg, XR 50mg, XR 200mg, XR 300mg) are now available in Uruguay.
• Emcure Pharmaceuticals Ltd.coreTechnology or IntegrationSource of pharmaceutical products including STIGRA (Dolutegravir) and INBEC (Abacavir + Dolutegravir + Lamivudina). Products are antiretroviral medications manufactured in India under quality standards.
• Brazil Ministry of HealthcoreOthersIn the context of the bilateral health agreement between Uruguay and Brazil, Brazil's Ministry of Health acquired medications from Uruguay needed for ICU patients during the COVID-19 pandemic. Products were supplied to healthcare centers in Rio Grande do Sul and Santa Catarina states.
• World Health Organization (WHO)coreStrategic or Co-development PartnerLibra operates under WHO Good Manufacturing Practices and WHO Good Storage and Distribution Practices. Some products like Lamicavir are prequalified by WHO for use in international health programs.

Scale indicators4 records

Recent moves9 records

Expansion highlights5 records

Broad incumbents

• Laboratorios Roemmers: Argentine pharmaceutical manufacturer with a broad specialty and generic portfolio across Latin America. Comparable as a regional LatAm pharma manufacturer with multi-country commercialization, though substantially larger and more diversified than Libra.
• EMS Pharma: Brazilian pharmaceutical manufacturer with a large generics portfolio, including ARV and cardiovascular products. Comparable as a LatAm generic and specialty manufacturer with overlapping therapeutic categories (ARVs, anticoagulants).
• Laboratorios Bagó: Argentine pharmaceutical group with manufacturing, branded specialty, and animal health operations across Latin America. Comparable as a multi-country LatAm pharma manufacturer competing for similar hospital and government contracts.
• Eurofarma Laboratórios: Brazilian pharmaceutical company with one of the broadest generic and specialty portfolios in Latin America, including injectable and ARV products. Comparable as a regional manufacturer with injectable antibiotics and ARV manufacturing overlap.

Direct peers

• Laboratorios Gador: Argentine pharmaceutical company with branded specialty and generic products distributed across Latin America. Comparable as a mid-sized regional pharma manufacturer with similar export-oriented commercial model.
• Genomma Lab Internacional: Latin American pharmaceutical company with presence in over 18 countries, distributing branded specialty and OTC products. Comparable as a multi-country LatAm pharma with representation and distribution model.
• Cristália: Brazilian pharmaceutical manufacturer specializing in sterile injectable products, including antibiotics and hospital medicines. Directly comparable for injectable antibiotics manufacturing capabilities and ANVISA GMP-registered production.
• Laboratorio Chile (Teva): Chilean pharmaceutical manufacturer (now part of Teva) with a broad portfolio of specialty and generic products across Latin America. Comparable as a regional LatAm pharma manufacturer with similar in-country distribution and export model.
• Megalabs: Latin American pharmaceutical company with operations in multiple countries, focused on specialty and branded generics. Comparable as a regional LatAm pharma company with similar therapeutic area focus and in-country distribution.

Regional players

• Aspen Pharmacare: South African-headquartered global pharmaceutical manufacturer with a strong ARV and injectable portfolio. Comparable as a manufacturer of ARV and injectable antibiotics targeting emerging markets and global health programs; operates in different geographic core but in the same therapeutic categories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratorio Libra